Consainsights logo
Reports / Neurodegenerative Disease Market

Neurodegenerative Disease Market

Neurodegenerative Disease Market Research Report – Segmented By Indication Type (Alzheimer's Disease, Huntington Disease, Multiple Sclerosis, Other Indication Types, Parkinson's Disease), Drug Type (Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, N-methyl-D-aspartate Receptor antagonists, Other Drug Types) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Neurodegenerative Disease Market from Consainsights analyses the Neurodegenerative Disease Market in the Life Sciences industry over the forecast period to 2026.

Neurodegenerative Disease research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Neurodegenerative Disease segmentation includes Indication Type, Drug Type and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Indication Type, the Neurodegenerative Disease Market analysis covers Alzheimer's Disease, Huntington Disease, Multiple Sclerosis, Other Indication Types, Parkinson's Disease.

Based on the Drug Type, the Neurodegenerative Disease Market analysis covers Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, N-methyl-D-aspartate Receptor antagonists, Other Drug Types.

Key companies operating in the market include AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical, UCB SA, Biogen Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

  • Revenue Share (%), By Indication Type (2019)
    Revenue Share (%), By Indication Type (2019)
  • Revenue Share (%), By Drug Type (2019)
    Revenue Share (%), By Drug Type (2019)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Indication Type

By Indication Type, The Global Neurodegenerative Disease Market analysis covers Alzheimer's Disease, Huntington Disease, Multiple Sclerosis, Other Indication Types, Parkinson's Disease.

Global Neurodegenerative Disease Market - Historical, Forecast Market Sizes (Us$ Mn), By Indication Type, 2019-2027
Global Neurodegenerative Disease Market - Historical, Forecast Market Sizes (Us$ Mn), By Indication Type, 2019-2027

The Alzheimer's Disease segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Alzheimer's Disease: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Alzheimer's Disease: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)

The Huntington Disease segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Huntington Disease: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Huntington Disease: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)

The Multiple Sclerosis segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Multiple Sclerosis: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Multiple Sclerosis: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)

The Other Indication Types segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Indication Types: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Other Indication Types: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)

The Parkinson's Disease segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Parkinson's Disease: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Parkinson's Disease: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
04

By Drug Type

By Drug Type, The Global Neurodegenerative Disease Market analysis covers Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, N-methyl-D-aspartate Receptor antagonists, Other Drug Types.

Global Neurodegenerative Disease Market - Historical, Forecast Market Sizes (Us$ Mn), By Drug Type, 2019-2027
Global Neurodegenerative Disease Market - Historical, Forecast Market Sizes (Us$ Mn), By Drug Type, 2019-2027

The Cholinesterase Inhibitors segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Cholinesterase Inhibitors: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Cholinesterase Inhibitors: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)

The Dopamine Agonists segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Dopamine Agonists: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Dopamine Agonists: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)

The Immunomodulatory Drugs segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Immunomodulatory Drugs: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Immunomodulatory Drugs: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)

The N-methyl-D-aspartate Receptor antagonists segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

N-methyl-D-aspartate Receptor antagonists: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
N-methyl-D-aspartate Receptor antagonists: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)

The Other Drug Types segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Drug Types: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
Other Drug Types: Global Neurodegenerative Disease Market Revenue Opportunity (Us$ Mn)
05

North America

Based on the North America, the Neurodegenerative Disease Market analysis covers United States, Canada.

North America Map
North America Neurodegenerative Disease Market Size, 2019-2027 (Us$ Mn)
North America Neurodegenerative Disease Size, 2019-2027 (Us$ Mn)
North America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
North America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
North America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
North America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United States Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
United States Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
United States Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United States Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Canada Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Canada Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Canada Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Canada Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
06

Europe

Based on the Europe, the Neurodegenerative Disease Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Europe Map
Europe Neurodegenerative Disease Market Size, 2019-2027 (Us$ Mn)
Europe Neurodegenerative Disease Size, 2019-2027 (Us$ Mn)
Europe Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Europe Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Europe Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Europe Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Germany Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Germany Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Germany Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Germany Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United Kingdom Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
United Kingdom Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
United Kingdom Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
United Kingdom Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
France Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
France Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
France Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
France Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Spain Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Spain Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Spain Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Spain Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Russia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Russia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Russia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Russia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Italy Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Italy Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Italy Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Italy Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Europe Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Rest of Europe Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Rest of Europe Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Europe Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
07

Asia-Pacific

Based on the Asia-Pacific, the Neurodegenerative Disease Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Asia-Pacific Map
Asia-Pacific Neurodegenerative Disease Market Size, 2019-2027 (Us$ Mn)
Asia-Pacific Neurodegenerative Disease Size, 2019-2027 (Us$ Mn)
Asia-Pacific Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Asia-Pacific Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Asia-Pacific Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Asia-Pacific Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
China Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
China Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
China Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
China Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Japan Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Japan Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Japan Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Japan Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
India Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
India Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
India Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
India Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Southeast Asia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Southeast Asia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Southeast Asia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Southeast Asia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Australia & New Zealand Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Australia & New Zealand Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Australia & New Zealand Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Australia & New Zealand Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Asia-Pacific Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Rest of Asia-Pacific Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Rest of Asia-Pacific Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Asia-Pacific Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Neurodegenerative Disease Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Neurodegenerative Disease Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Neurodegenerative Disease Size, 2019-2027 (Us$ Mn)
Middle East & Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Middle East & Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Middle East & Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East & Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Middle East Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Middle East Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Middle East Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Middle East & Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Rest of Middle East & Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Rest of Middle East & Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Middle East & Africa Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
09

Latin America

Based on the Latin America, the Neurodegenerative Disease Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Latin America Map
Latin America Neurodegenerative Disease Market Size, 2019-2027 (Us$ Mn)
Latin America Neurodegenerative Disease Size, 2019-2027 (Us$ Mn)
Latin America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Latin America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Latin America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Latin America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Brazil Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Brazil Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Brazil Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Brazil Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Argentina Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Argentina Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Argentina Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Argentina Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Mexico Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Mexico Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Mexico Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Mexico Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Colombia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Colombia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Colombia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Colombia Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Latin America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Rest of Latin America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Indication Type, 2019-2027
Rest of Latin America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
Rest of Latin America Neurodegenerative Disease Market - Historical, Forecast Market Sizes (US$ MN), By Drug Type, 2019-2027
10

Company Analysis

  • AbbVie Inc.
  • Amneal Pharmaceuticals Inc.
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche Ltd
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical
  • UCB SA
  • Biogen Inc.